{"result": "(\"entity\"<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Department of Endocrinology and Nutrition at the University Clinic of Navarra focuses on research and education in endocrinology and nutrition.)\n##\n(\"entity\"<|>CLÍNICA UNIVERSIDAD DE NAVARRA<|>ORGANIZATION<|>The University Clinic of Navarra is a medical institution where the Department of Endocrinology and Nutrition operates.)\n##\n(\"entity\"<|>UNIVERSIDAD DE ZARAGOZA<|>ORGANIZATION<|>The University of Zaragoza is an educational institution where the individual served as an associate professor in Health Sciences.)\n##\n(\"entity\"<|>UNIVERSIDAD DE NAVARRA<|>ORGANIZATION<|>The University of Navarra is an educational institution where the individual is currently an associate professor of Endocrinology.)\n##\n(\"entity\"<|>SEEN<|>ORGANIZATION<|>The Spanish Society of Endocrinology and Nutrition (SEEN) is a professional organization focused on the field of endocrinology and nutrition.)\n##\n(\"entity\"<|>AVANCES EN DIABETOLOGÍA<|>ORGANIZATION<|>Advances in Diabetology is a journal where the individual served as an associate editor.)\n##\n(\"entity\"<|>ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>Endocrinology and Nutrition is a journal where the individual served as an associate editor.)\n##\n(\"entity\"<|>ENDOCRINOLOGÍA, DIABETES Y NUTRICIÓN<|>ORGANIZATION<|>Endocrinology, Diabetes and Nutrition is a journal where the individual served as deputy editor.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic health condition that the individual has researched extensively.)\n##\n(\"entity\"<|>HIPERCOLESTEROLEMIA<|>EVENT<|>Hypercholesterolemia is a condition characterized by high cholesterol levels, which the individual has studied.)\n##\n(\"entity\"<|>CELULAS MESENQUIMALES<|>EVENT<|>Mesenchymal cells are a type of stem cell that the individual has researched in relation to diabetes treatment.)\n##\n(\"relationship\"<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>CLÍNICA UNIVERSIDAD DE NAVARRA<|>The Department of Endocrinology and Nutrition operates within the University Clinic of Navarra<|>8)\n##\n(\"relationship\"<|>UNIVERSIDAD DE NAVARRA<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>The University of Navarra is the institution where the Department of Endocrinology and Nutrition is located<|>8)\n##\n(\"relationship\"<|>UNIVERSIDAD DE NAVARRA<|>UNIVERSIDAD DE ZARAGOZA<|>The individual has taught at both the University of Navarra and the University of Zaragoza<|>5)\n##\n(\"relationship\"<|>SEEN<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>The individual is involved with the SEEN, which relates to their work in the Department of Endocrinology and Nutrition<|>6)\n##\n(\"relationship\"<|>AVANCES EN DIABETOLOGÍA<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>The individual served as an associate editor for the journal, which is related to their work in endocrinology<|>7)\n##\n(\"relationship\"<|>ENDOCRINOLOGÍA Y NUTRICIÓN<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>The individual served as an associate editor for the journal, which is related to their work in the department<|>7)\n##\n(\"relationship\"<|>ENDOCRINOLOGÍA, DIABETES Y NUTRICIÓN<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>The individual served as deputy editor for the journal, which is related to their work in the department<|>7)\n##\n(\"relationship\"<|>DIABETES<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>The individual has conducted research on diabetes within the Department of Endocrinology and Nutrition<|>8)\n##\n(\"relationship\"<|>HIPERCOLESTEROLEMIA<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>The individual has researched hypercholesterolemia in the context of their work in the department<|>8)\n##\n(\"relationship\"<|>CELULAS MESENQUIMALES<|>DEPARTAMENTO DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>The individual has researched mesenchymal cells in relation to diabetes treatment in the department<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Departamento de Endocrinología y Nutrición de la Clínica Universidad de Navarra. Tutor de residentes desde noviembre 2016 hasta agosto 2018.\n\n- Ha ejercido como profesor asociado en Ciencias de la Salud de la Facultad de Medicina de la Universidad de Zaragoza y actualmente es profesor asociado de Endocrinología en la Facultad de Medicina de la Universidad de Navarra (2007-). Sus áreas de investigación principales son diabetes tipo 1 y tratamiento con células mesenquimales, nefropatía diabética y diabetes y riesgo cardiovascular.\n\n- Ha sido y es investigador principal e investigador colaborador de distintos proyectos de investigación, fundamentalmente relacionados con el área de diabetes. Ha sido editor asociado de la revista Avances en Diabetología (2011-2014) y Endocrinología y Nutrición (2014-2017). Desde abril de 2017 hasta abril de 2019 ha sido editor jefe adjunto de la revista Endocrinología, Diabetes y Nutrición.\n\n- Ha pertenecido a la junta de la Sociedad Española de Endocrinología y Nutrición como responsable de los programas de docencia para residentes y formación continuada de especialistas. Asimismo, es miembro de los grupos de trabajo de Diabetes de la Sociedad Española de Endocrinología y Nutrición, del Grupo de Consensos de la Sociedad Española de Diabetes y del Grupo de lípidos de la Sociedad Española de Endocrinología y Nutrición.\n\n- Presidente electo de la SEEN (2019).\n---\n# 8.3 Lípidos\n\n## 24 ¿Cuál de las siguientes opciones es falsa en relación con las hipercolesterolemias?\n\nA. El alirocumab es un nuevo fármaco que reduce drásticamente los niveles de colesterol LDL.\nB. En la hipercolesterolemia homocigota, los niveles de colesterol LDL suelen ser superiores a 500 mg/dl.\nC. Los xantomas palmares suelen aparecer en la hiperlipidemia familiar combinada.\nD. En pacientes con muy alto riesgo cardiovascular (diabetes y enfermedad cardiovascular), el tratamiento debe prescribirse para tener niveles de colesterol LDL inferiores a 70 mg/dl.\n\n### COMENTARIO\n\nUn xantoma es una afección cutánea caracterizada por la formación de placas o nódulos más o menos planos, amarillos, ligeramente elevados y de tamaño diverso. Generalmente dependen de una afectación del hígado o de un trastorno metabólico de los lípidos. Se originan por trastornos hiperlipidémicos hereditarios o adquiridos y son el acúmulo de macrófagos espumosos en tejido conectivo dérmico y tendones donde se producen masas tumorales. En la hipercolesterolemia familiar aparecen xantomas tendinosos, mientras que los xantomas palmares son habituales en la disbetalipoproteinemia. Este trastorno es raro, con una frecuencia de una por cada 10.000 personas, y fundamentalmente se debe a una homocigosis en la apolipoproteína E (apo E), presentando el genotipo apo E2 en homocigosis. Dado que la apo E desempeña un papel crucial en el catabolismo de los quilomicrones y restos de lipoproteínas de muy baja densidad (VLDL), estos sujetos afectados presentan elevaciones de triglicéridos y colesterol VLDL, además de quilomicrones en ayunas. Pueden presentar xantomas y depósitos de colesterol en los surcos palmares.\n\nLa hipercolesterolemia se caracteriza por un aumento del colesterol plasmático en ayunas y niveles normales de triglicéridos. Estos niveles elevados se asocian a aumento de las lipoproteínas de baja densidad (LDL) puesto que las LDL son las portadoras del 65-75% del colesterol plasmático total, con fenotipo IIa y suero transparente. Son tres las entidades primarias relacionadas con este grupo:\n\n1. Hipercolesterolemia familiar (HF). Es un trastorno genético codominante que en forma heterocigota se da aproximadamente en uno de cada 500 individuos. Se debe fundamentalmente a mutaciones en el receptor de LDL y hasta la fecha se han descrito más de 200 mutaciones en el receptor. Los niveles de LDL colesterol están elevados al nacer y permanecen así durante toda la vida. En adultos no tratados, los niveles oscilan entre 275 y 500 mg/dl, mientras que los niveles de triglicéridos y HDL permanecen normales e incluso bajos en estos últimos. Se observan xantomas tendinosos que son depósitos intra- y extracelulares de colesterol en los tendones. La forma homocigota de hipercolesterolemia familiar tiene una frecuencia de un individuo por millón y se acompaña de niveles de colesterol plasmático superiores a 500 mg/dl.\n\n2. Hipercolesterolemia poligénica. La mayoría de las hipercolesterolemias moderadas [nive\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}